We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
–
Cap. Flow
+$3.41B
Cap. Flow %
101.25%
Top 10 Hldgs %
50.48%
Holding
489
New
489
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$483M
2
NVDA icon
NVIDIA
NVDA
+$247M
3
AAPL icon
Apple
AAPL
+$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Healthcare 4.63%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
API
451
Agora
API
$331M
$193K 0.01%
+54,555
New +$231K
IOVA icon
452
Iovance Biotherapeutics
IOVA
$2.23B
$191K 0.01%
+54,429
New +$174K
RLAY icon
453
Relay Therapeutics
RLAY
$4.34B
$188K 0.01%
+18,933
New +$169K
QURE icon
454
uniQure
QURE
$2.77B
$186K 0.01%
+11,348
New +$230K
ORIC icon
455
Oric Pharmaceuticals
ORIC
$1.11B
$184K 0.01%
+14,517
New +$165K
MNKD icon
456
MannKind Corp
MNKD
$1.25B
$179K 0.01%
+73,100
New +$326K
TSHA icon
457
Taysha Gene Therapies
TSHA
$1.71B
$169K 0.01%
+37,699
New +$175K
GERN icon
458
Geron
GERN
$924M
$165K ﹤0.01%
+111,070
New +$169K
F icon
459
Ford
F
$56.7B
$161K ﹤0.01%
+13,975
New +$184K
PGEN icon
460
Precigen
PGEN
$1.76B
$155K ﹤0.01%
+40,126
New +$165K
VIR icon
461
Vir Biotechnology
VIR
$1.59B
$151K ﹤0.01%
+16,896
New +$135K
CTMX icon
462
CytomX Therapeutics
CTMX
$788M
$142K ﹤0.01%
+30,147
New +$153K
ANNX icon
463
Annexon
ANNX
$950M
$142K ﹤0.01%
+25,552
New +$144K
KURA icon
464
Kura Oncology
KURA
$964M
$137K ﹤0.01%
+16,864
New +$145K
SLS icon
465
SELLAS Life Sciences
SLS
$2.59B
$133K ﹤0.01%
+31,354
New +$140K
CMPX icon
466
Compass Therapeutics
CMPX
$369M
$130K ﹤0.01%
+24,622
New +$142K
SVRA icon
467
Savara
SVRA
$1.13B
$130K ﹤0.01%
+23,752
New +$132K
SANA icon
468
Sana Biotechnology
SANA
$877M
$128K ﹤0.01%
+44,446
New +$175K
SPRY icon
469
ARS Pharmaceuticals
SPRY
$695M
$119K ﹤0.01%
+14,787
New +$142K
REPL icon
470
Replimune Group
REPL
$859M
$114K ﹤0.01%
+14,893
New +$114K
IRWD icon
471
Ironwood Pharmaceuticals
IRWD
$635M
$95.6K ﹤0.01%
+27,230
New +$112K
PRME icon
472
Prime Medicine
PRME
$565M
$94.3K ﹤0.01%
+27,099
New +$103K
ABSI icon
473
Absci
ABSI
$1.4B
$90.9K ﹤0.01%
+30,290
New +$87.7K
ALT icon
474
Altimmune
ALT
$558M
$89.5K ﹤0.01%
+29,072
New +$123K
EBS icon
475
Emergent Biosolutions
EBS
$394M
$88.9K ﹤0.01%
+10,710
New +$111K
16 17 18
19
20

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for E Fund Management, which disclosed 489 positions worth $3.37B. Its ten largest holdings account for 50% of the portfolio.

Its largest position is Pinduoduo: 4,593,053 shares worth $469M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q1 2026 buy was Pinduoduo: 4,593,053 shares worth $469M.
  • E Fund Management's ten largest holdings make up 50% of its $3.37B portfolio in Q1 2026.
  • E Fund Management disclosed 489 positions in Q1 2026, its first 13F filing on record.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.